In an article published on its website, the CNRS Chemistry Institute highlights the work of Rachel Auzély-Velty, Professor at the Université Grenoble Alpes at Cermav, and her collaborators, who have developed a new injectable hyaluronic acid gel that promises to slow osteoarthritis while allowing doctors to monitor its action in real time. This important advance, published in the journal Theranostics, could transform the treatment of this degenerative disease.
The article is available on the CNRS Chemistry Institute website : https://www.inc.cnrs.fr/fr/cnrsinfo/un-gel-revolutionnaire-dacide-hyaluronique-pour-simultanement-suivre-et-traiter-larthrose
The work is published in the journal Theranostics :
A self-healing radiopaque hyaluronic acid hydrogel as a new injectable biomaterial for precision medicine in osteoarthritis
Moustoifa Said, Clément Tavakoli, Chloé Dumot, Karine Toupet, Cécile Olivier, Alexia Gilles, Marie Maumus, Yuxi Clara Dong, Nora Collomb, Céline Auxenfans, Anaïck Moisan, Bertrand Favier, Benoit Chovelon, Emmanuel Luc Barbier, David Peter, Cormode, Emmanuel Brun, Hélène Elleaume, Marlène Wiart, Olivier Detante, Claire Rome, Danièle Noël & Rachel Auzély-Velty
Theranostics 2025
https://doi.org/10.7150/thno.104551
